Cargando…
Tumor‐derived endomucin promotes colorectal cancer proliferation and metastasis
BACKGROUND: Endomucin (EMCN) is a type I transmembrane glycoprotein and a mucin‐like component of the endothelial cell glycocalyx. The mechanism of EMCN action in colorectal cancer (CRC) remains unclear. AIMS: Our aim was to explore the role of EMCN in the progression of CRC. MATERIALS & METHODS...
Autores principales: | Huang, Qi, Li, Xue‐mei, Sun, Jing‐ping, Zhou, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939191/ https://www.ncbi.nlm.nih.gov/pubmed/35971319 http://dx.doi.org/10.1002/cam4.5055 |
Ejemplares similares
-
Research progress on the structure and function of endomucin
por: Zhang, Guoxin, et al.
Publicado: (2021) -
Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity
por: Hu, Zhengping, et al.
Publicado: (2020) -
Endomucin, a CD34-like sialomucin, marks hematopoietic stem cells throughout development
por: Matsubara, Azusa, et al.
Publicado: (2005) -
Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling
por: Park-Windhol, Cindy, et al.
Publicado: (2017) -
Endomucin prevents leukocyte–endothelial cell adhesion and has a critical role under resting and inflammatory conditions
por: Zahr, Alisar, et al.
Publicado: (2016)